COMPARATIVE EFFECTS OF HIGH-DOSE ATORVASTATIN VERSUS ROSUVASTATIN ON LIPID PARAMETERS, OXIDIZED-LDL AND PCSK9 LEVELS IN ACUTE CORONARY SYNDROME

Yalçın, Meryem ÜlküAltunkeser, Bülent BehlülTuncez, AbdullahÖztürk, BahadırTezcan, HüseyinAteş, Muhammet S.Yılmaz, Canan2020-03-262020-03-2620180021-91501879-1484https://dx.doi.org/10.1016/j.atherosclerosis.2018.06.719https://hdl.handle.net/20.500.12395/3641286th Congress of the European-Atherosclerosis-Society (EAS) -- MAY 05-08, 2018 -- Lisbon, PORTUGAL[Abstract not Available]en10.1016/j.atherosclerosis.2018.06.719info:eu-repo/semantics/closedAccessCOMPARATIVE EFFECTS OF HIGH-DOSE ATORVASTATIN VERSUS ROSUVASTATIN ON LIPID PARAMETERS, OXIDIZED-LDL AND PCSK9 LEVELS IN ACUTE CORONARY SYNDROMEConference Object275E228E228WOS:000442512600731Q1